drugset / Trial / NCT00414453
Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis
Phase 4
Terminated
19 enrolled
University of Rochester
Endo USA Inc., a Keenova Therapeutics Company · collab
RandomizedCrossoverTriple-blindTreatment
Summary
This study will determine whether treatment with an extended-release opioid or topical lidocaine is effective in relieving distal symmetric lower extremity burning pain associated with multiple sclerosis (MS). If treatment with topical lidocaine is efficacious, it will have important implications for understanding this chronic pain syndrome, which is widely assumed to be caused by central nervous system pathology.
Timeline
- Start
- 2007-01
- Primary completion
- 2011-08
- Completion
- 2011-08